Bunge Global SA saw a director purchase 1,500 shares at $107.60, signaling insider confidence. Analysts have set a mean price target of $138.30, implying a 28.3% upside, driven by strong Q2 performance in soybeans and softseeds that raised earnings outlook. The company’s solid operational results and positive earnings revisions suggest potential stock price growth ahead.
Several analysts have reduced their price targets for CRH plc, a leading building materials company, with RBC Capital lowering its target from $165 to $135 while keeping an Outperform rating. Despite the cuts, the new targets still imply significant ...
Ether futures open interest on Binance increased by 2.27% in ETH terms over 69 hours through October 8, reaching about 2.33 million ETH. However, the USDT-denominated value of these positions fell by 6.58% to approximately $5.77 billion due to a decl...
Ether's price surged 71% in the third quarter, reflecting strong market performance. Despite this rise, the proportion of Ether held at a profit remains below historical alert thresholds, indicating the market has not yet reached overbought or excess...
Intel's stock has surged over 200% in 2026, driven by strong revenue growth and strategic focus under CEO Lip-Bu Tan. The company reported a 25.4% revenue increase in Q2 and has beaten earnings estimates for seven consecutive quarters. Despite this, ...
Oppenheimer upgraded Humana's price target from $405 to $475, citing strong performance in Medicare Advantage plans where 95% of members are in four-star or higher rated plans. This upgrade implies a potential 22.7% upside from Humana's current stock...
